Delivery Order SPE2DB20D9331-SPE2DB25FL1S4
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on July 18, 2025. The delivery order, which must be completed by August 8, 2025, is for Stelara 90 mg/mL syringes and was issued without a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. The award was issued without a set-aside designation, demonstrating the company's competitive strength in federal pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on July 17, 2025. The contract calls for delivery of Stelara 90 mg/ml syringes, a biologic medication used to treat immunological conditions, with an ultimate completion date of August 7, 2025. This delivery order carries no set-aside designation and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 12, 2025. This delivery order, without set-aside designation, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare requirements. The award is expected to be completed by October 3, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 12, 2025, for the supply of Stelara 90 mg/mL syringes under a firm fixed-price contract valued at $16,249.95. The order is set to be completed by September 3, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. This delivery order was issued by the Medical Supply Chain, a defense-focused federal agency,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, issued under the SPE2DB Indefinite Delivery Contract (valued at $499,999,999 through November 2026), calls for the delivery of Stelara 90 mg/mL syringes to support Department of Defense healthcare facilities. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1S4Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $16,249.95 from the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, issued without set-aside designation, covers the supply of Stelara 90 mg/mL syringes to support military healthcare operations. This award represents a single task order executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive portfolio of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. The Indefinite Delivery Contract vehicle (SPE2DB program) enables the DLA to issue firm fixed-price delivery orders for medical supplies supporting Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a consistent track record of delivering specialized pharmaceutical products ranging from oncology treatments and contraceptive devices to vaccines and injectable medications. The delivery is scheduled for completion by September 3, 2025, with performance taking place at the company's Park Ridge, Illinois location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/12/25 |